NO20043008L - Procedure for the treatment of bacterial infections in dogs and cats - Google Patents

Procedure for the treatment of bacterial infections in dogs and cats

Info

Publication number
NO20043008L
NO20043008L NO20043008A NO20043008A NO20043008L NO 20043008 L NO20043008 L NO 20043008L NO 20043008 A NO20043008 A NO 20043008A NO 20043008 A NO20043008 A NO 20043008A NO 20043008 L NO20043008 L NO 20043008L
Authority
NO
Norway
Prior art keywords
cats
dogs
procedure
treatment
bacterial infections
Prior art date
Application number
NO20043008A
Other languages
Norwegian (no)
Inventor
Brian Scott Bronk
Simon Edward Blanchflower
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0130694.3A external-priority patent/GB0130694D0/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20043008L publication Critical patent/NO20043008L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO20043008A 2001-12-21 2004-07-15 Procedure for the treatment of bacterial infections in dogs and cats NO20043008L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0130694.3A GB0130694D0 (en) 2001-12-21 2001-12-21 Treatment
US35996102P 2002-02-27 2002-02-27
US39893302P 2002-07-26 2002-07-26
PCT/IB2002/004741 WO2003053522A1 (en) 2001-12-21 2002-11-13 Methods of treating bacterial infections in dogs and cats

Publications (1)

Publication Number Publication Date
NO20043008L true NO20043008L (en) 2004-09-01

Family

ID=27256361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043008A NO20043008L (en) 2001-12-21 2004-07-15 Procedure for the treatment of bacterial infections in dogs and cats

Country Status (12)

Country Link
EP (1) EP1455900A1 (en)
JP (1) JP2005524611A (en)
CN (1) CN1606463A (en)
AR (1) AR037594A1 (en)
AU (1) AU2002348985A1 (en)
BR (1) BR0215070A (en)
CA (1) CA2470995A1 (en)
IL (1) IL162103A0 (en)
NO (1) NO20043008L (en)
PL (1) PL370624A1 (en)
TW (1) TW200301126A (en)
WO (1) WO2003053522A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012215A (en) * 2004-04-22 2007-04-19 Pfizer Prod Inc Method of stabilizing disordered cefovecin sodium salt.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE171705T1 (en) * 1989-03-30 1998-10-15 Pfizer CEPHALOSPORINS AND THEIR HOMOLOGUES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation

Also Published As

Publication number Publication date
PL370624A1 (en) 2005-05-30
CA2470995A1 (en) 2003-07-03
TW200301126A (en) 2003-07-01
AU2002348985A1 (en) 2003-07-09
WO2003053522A1 (en) 2003-07-03
EP1455900A1 (en) 2004-09-15
CN1606463A (en) 2005-04-13
AR037594A1 (en) 2004-11-17
BR0215070A (en) 2004-11-09
IL162103A0 (en) 2005-11-20
JP2005524611A (en) 2005-08-18

Similar Documents

Publication Publication Date Title
DK1448234T3 (en) Formulations comprising a cephalosporin compound and their use in the treatment of bacterial infections in cats and dogs
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
NO20052362D0 (en) Methods of administering dalbavancin for the treatment of bacterial infections
NO20025204D0 (en) Compounds and methods for treating and preventing bacterial infections
ZA200507857B (en) Compositions for treating microbial and parasitic infections in cattle and other animals
HUS2200036I1 (en) Use of dihydroimidazolones for the treatment of dogs
DK1239872T3 (en) Enzyme treatment for digestive tract infections
EP1531828A4 (en) Methods of treating bacterial infections and diseases associated therewith
DE60036249D1 (en) Field effect transistor and its production method
AU2003279526A1 (en) Identifying and treating vaginal infections
EP1461047A4 (en) Compositions and methods for animal treatment
EP1389972A4 (en) Animal treatment and marking system
PT1227827E (en) ACID-LACTICAL BACTERIA FOR GIARDIASE TREATMENT AND / OR PROPHYLAXIS
HK1052643A1 (en) Use of pleuromutilin derivatives in the manufacture of a mediament for transdermal treatment of bacterial infections in humans and animals
NO20043445L (en) Combination therapy for the treatment of bacterial infections
NO20043008L (en) Procedure for the treatment of bacterial infections in dogs and cats
DE60336244D1 (en) ARTICLE TREATMENT SYSTEM AND METHOD
AU2003290506A8 (en) Methods and devices for treating severe peripheral bacterial infections
IL166122A0 (en) Methods of treating microbial infections in humansand animals
GB0323849D0 (en) Animal treatment system and method thereof
AU2003230853A1 (en) Method and systems for disinfecting animal bedding and stalls
AP2256A (en) Treatment of parasitic infections in humans and animals.
HK1069739A1 (en) Compositions and methods for treatment of microbial infections
AU2002229446A1 (en) Hog farming process and barn
SE0302375D0 (en) Method and device for treating microbial infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application